StockData
Gossamer Bio, Inc. logo

Gossamer Bio, Inc. (GOSS) stock

GOSSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$10.72−0.51 (-4.54%)

Close on Nov 20, 2026Market cap $5.24BP/E –Yield –

Gossamer Bio gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Gossamer Bio

Gossamer Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Gossamer Bio figures

See a number that looks wrong?